Not Yet Recruiting OBSERVATIONAL NCT06649838
Customized Circulating Tumor DNA Testing for Cervical Cancer Recurrence Surveillance and Treatment Decisions
Sponsor: Peking Union Medical College Hospital
Conditions
Biomarker Cervical Cancer CtDNA Immunotherapy
Updated 2 times since 2024 Last updated: Dec 16, 2024 Started: Dec 20, 2024 Primary completion: Mar 2, 2025 Completion: Oct 2, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06649838, this observational or N/A phase trial focuses on Biomarker and Cervical Cancer and remains actively recruiting participants. Sponsored by Peking Union Medical College Hospital, it has been updated 2 times since 2024, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
2 versions recorded-
Jan 2025 — Present [monthly]
Not Yet Recruiting
-
Nov 2024 — Jan 2025 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Peking Union Medical College Hospital
Data source: Peking Union Medical College Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.